Search

Search Results

• 

  Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience

  Roberto Giulianelli, Barbara Cristina Gentile, Gabriella Mirabile, Luca Albanesi, Paola Tariciotti, Giorgio Rizzo, Maurizio Buscarini, Mauro Vermiglio

  272-276

  2017-12-31

  Published: December 31, 2017

  1442

  PDF: 758
• 

  Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?

  Daniele Minardi, Giulio Milanese, Gianni Parri, Vito Lacetera, Giovanni Muzzonigro

  13-16

  2016-03-31

  Published: March 31, 2016

  2405

  PDF: 1351
• 

  Blue light cystoscopy with hexylaminolevulinate: Our 7 years experience

  Vito Lacetera, Ubaldo Cantoro, Lorenzo Montesi, Daniele Cantoro, Bernardo Cervelli, Antonio Cicetti, Giuliana Gabrielloni, Domenico Milella, Michele Montesi, Roberto Morcellini, Gianni Parri, Emilio Recanatini, Valerio Beatrici

  39-41

  2017-03-31

  Published: March 31, 2017

  1534

  PDF: 788
• 

  Effectivity of intravescical thermo-chemotherapy prophylaxis for patients with high recurrence and progression risk for non-muscle invasive bladder cancer

  Ali Serdar Gözen, Paolo Umari, Walter Scheitlin, Fuat Ernis Su, Yigit Akin, Jens Rassweiler

  102-105

  2017-06-30

  Published: June 30, 2017

  2041

  PDF: 1141

• Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) patients among Arab urologists

  Mohamad Moussa, Mohamad Abou Chakra, Neal D. Shore, Athanasios Papatsoris, Yasser Farahat, Michael A. O’Donnell

  2024-03-19

  Published: March 19, 2024

  1012

  PDF: 241
• 

  New concept in urologic surgery: The total extended genital sparing radical cystectomy in women

  Antonio Cisternino, Lorenzo Capone, Antonio Rosati, Costanzo Latiano, Nicola Sebastio, Antonio Colella, Giuseppe Cretì

  2023-05-22

  Published: May 22, 2023

  1519

  PDF: 647